Initial unemployment filings in Oregon fell last week, reflecting a slight easing in layoffs, while national figures held steady and other states experienced sharp swings.
Target is launching its largest-ever spring beauty collection, introducing over 3,000 new, predominantly budget-friendly items alongside redesigned in-store experiences and key leadership appointments, signaling a major strategic push to capture market share in the lucrative beauty sector.
NewtekOne (NASDAQ: NEWT) reported robust Q4 and full-year 2025 results, highlighting the third anniversary of its OCC-chartered bank. The financial holding company saw net income rise 16.4% to $80 million, driven by strong deposit growth, successful securitizations, and a focus on serving independent business owners with long-term, 'patient capital' loans.
Investors in Selangor Dredging Berhad (KLSE:SDRED) have faced an 11% total loss over the past year, underperforming the broader market's positive return. While the share price decline reflects recent operational headwinds, long-term holders have seen more modest erosion in value.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Monarch Casinos & Resorts (MCRI) will release its fourth-quarter financial results after Wednesday's market close, with analysts projecting modest revenue growth but heightened scrutiny on its high-end gaming segment performance.
Despite a significant stock pullback following its transformative $4.1 billion acquisition of Paycor, Paychex (PAYX) presents a compelling case for patient investors. This analysis explores the strategic rationale behind the deal, near-term integration pressures, and the long-term defensive appeal of its recurring-revenue model in a volatile market for small-business services.
Despite facing near-term pressures from a softer ad market and intensified competition, The Trade Desk's leadership in programmatic advertising and its scalable platform present a compelling case for patient investors eyeing the sector's structural shift.
Amidst market volatility, EVERTEC Inc. (EVTC) presents a compelling investment case. Trading at depressed valuation multiples, the Latin American transaction processing leader combines a 'boring but consistent' operational profile with significant potential for multiple expansion and steady growth, offering a unique risk/reward balance for patient investors.
With interest rate cuts on the horizon, America's largest homebuilder, D.R. Horton, is positioned to capitalize on pent-up demand from millennials and a potential housing market recovery, presenting a compelling value case for patient investors.
In his first podcast since leaving the FBI, former co-deputy director Dan Bongino staunchly defended the agency's handling of the Jeffrey Epstein files, attacked internal critics, and revealed details of a conversation with former President Donald Trump, who suggested his media platform might be more valuable than his government post.
Coca-Cola FEMSA (KOF), the world's largest Coca-Cola bottler, presents a compelling investment case. Despite facing currency headwinds, its dominant position in high-growth Latin American markets, fortress balance sheet, and strategic digital investments suggest significant upside potential for patient investors.
Once a high-flying SaaS leader, PagerDuty now trades near historic lows despite its critical role in digital operations. As the company navigates a painful pricing model transition, improving fundamentals and persistent takeover speculation present a compelling bull case for patient investors.
BioNTech appoints Kylie Jimenez as its first Chief People Officer, a strategic move aimed at building the organizational and cultural backbone for its ambitious transition into a multi-product oncology company by 2030.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
Amidst a complex macroeconomic backdrop, a select group of Asian small-cap stocks is capturing attention for their distinct value propositions and growth narratives. We examine China Feihe, Digital China Holdings, and Thai Beverage, assessing their financial health and strategic positioning in volatile markets.
Amid economic headwinds and geopolitical tensions, discerning investors are scouring Asian markets for hidden gems. We spotlight three companies—from China's food sector to Taiwan's tech and Japan's chemicals—trading significantly below their estimated intrinsic value, offering potential upside for the patient investor.
In a strategic reshuffle following the exit of its product chief, Netflix has merged its product and technology divisions under veteran executive Elizabeth Stone, signaling a tighter integration of engineering and user experience.
The surge in popularity of weight-loss drugs like Ozempic and Wegovy is sending shockwaves far beyond the pharmacy, fundamentally altering consumer spending, challenging major corporations, and forcing a broad economic recalibration.
As the TSX rides a wave of positive earnings momentum, adventurous investors are turning their gaze to the penny stock arena. We analyze three micro-cap companies—Automotive Finco, Aurora Spine, and Wilton Resources—that are generating buzz, weighing their potential against significant financial risks.
